Similar articles

• Frequency and expression of mutational resistance to the 4-quinolone antibacterials.

  Smith JT. Smith JT. Scand J Infect Dis Suppl. 1986;49:115-23. Scand J Infect Dis Suppl. 1986. PMID: 3547618
• [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].

  Carlone NA, Cuffini AM, Tullio V, Savoia D, Cavallo GP. Carlone NA, et al. G Batteriol Virol Immunol. 1986 Jan-Jun;79(1-6):85-97. G Batteriol Virol Immunol. 1986. PMID: 3479370 Italian.
• In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.

  Van der Auwera P. Van der Auwera P. Infection. 1986 May-Jun;14(3):142-4. doi: 10.1007/BF01643481. Infection. 1986. PMID: 2942489
• The mode of action of 4-quinolones and possible mechanisms of resistance.

  Smith JT. Smith JT. J Antimicrob Chemother. 1986 Nov;18 Suppl D:21-9. doi: 10.1093/jac/18.supplement_d.21. J Antimicrob Chemother. 1986. PMID: 3542946 Review.
• Review of the 4-quinolones.

  Eggleston M, Park SY. Eggleston M, et al. Infect Control. 1987 Mar;8(3):119-25. doi: 10.1017/s0195941700067291. Infect Control. 1987. PMID: 3553053 Review.